These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Panés J; García-Olmo D; Van Assche G; Colombel JF; Reinisch W; Baumgart DC; Dignass A; Nachury M; Ferrante M; Kazemi-Shirazi L; Grimaud JC; de la Portilla F; Goldin E; Richard MP; Leselbaum A; Danese S; Lancet; 2016 Sep; 388(10051):1281-90. PubMed ID: 27477896 [TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem-cell therapy for perianal fistulas in Crohn's disease: a systematic review and meta-analysis. Cheng F; Huang Z; Li Z Tech Coloproctol; 2019 Jul; 23(7):613-623. PubMed ID: 31286287 [TBL] [Abstract][Full Text] [Related]
12. A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease. Lightner AL; Otero-Pineiro A; Reese J; Ream J; Nachand D; Adams AC; VanDenBossche A; Kurowski JA Inflamm Bowel Dis; 2023 Dec; 29(12):1912-1919. PubMed ID: 37263018 [TBL] [Abstract][Full Text] [Related]
13. Treatment effect of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of fistulizing Crohn's disease are durable at 12 months. Lightner AL; Pineiro AO; Reese J; Ream J; Nachand D; Adams AC; Dadgar N; Hull T Surgery; 2024 Apr; 175(4):984-990. PubMed ID: 38097485 [TBL] [Abstract][Full Text] [Related]
14. A phase I/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn's Disease. Swaroop S; Vuyyuru SK; Kante B; Kumar P; Mundhra SK; Arora U; Goyal A; Kandasamy D; Sharma R; Kabilan K; Kedia S; Dash NR; Ahuja V Stem Cell Res Ther; 2024 May; 15(1):140. PubMed ID: 38745184 [TBL] [Abstract][Full Text] [Related]
15. Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn's disease: A case series. Cabalzar-Wondberg D; Turina M; Biedermann L; Rogler G; Schreiner P Colorectal Dis; 2021 Jun; 23(6):1444-1450. PubMed ID: 33595166 [TBL] [Abstract][Full Text] [Related]
16. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Garcia-Olmo D; Herreros D; Pascual I; Pascual JA; Del-Valle E; Zorrilla J; De-La-Quintana P; Garcia-Arranz M; Pascual M Dis Colon Rectum; 2009 Jan; 52(1):79-86. PubMed ID: 19273960 [TBL] [Abstract][Full Text] [Related]
17. Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal Fistulas. Barnhoorn MC; Wasser MNJM; Roelofs H; Maljaars PWJ; Molendijk I; Bonsing BA; Oosten LEM; Dijkstra G; van der Woude CJ; Roelen DL; Zwaginga JJ; Verspaget HW; Fibbe WE; Hommes DW; Peeters KCMJ; van der Meulen-de Jong AE J Crohns Colitis; 2020 Jan; 14(1):64-70. PubMed ID: 31197361 [TBL] [Abstract][Full Text] [Related]
18. Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy. Lahat A; Assulin Y; Beer-Gabel M; Chowers Y J Crohns Colitis; 2012 Apr; 6(3):311-6. PubMed ID: 22405167 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stromal cells in the treatment of perianal fistulas in Crohn's disease. Castro-Poceiro J; Fernández-Clotet A; Panés J Immunotherapy; 2018 Oct; 10(14):1203-1217. PubMed ID: 30296868 [TBL] [Abstract][Full Text] [Related]
20. A Phase IB/IIA Study of Allogeneic, Bone Marrow-derived, Mesenchymal Stem Cells for the Treatment of Refractory Ileal-anal Anastomosis and Peripouch Fistulas in the Setting of Crohn's Disease of the Pouch. Lightner AL; Reese J; Ream J; Nachand D; Jia X; Pineiro AO; Dadgar N; Steele S; Hull T J Crohns Colitis; 2023 Apr; 17(4):480-488. PubMed ID: 36322714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]